DEF 14AThe Ballot
Spyre Therapeutics, Inc. files DEF 14A
Filed Apr 17, 2023 · 3y ago · Accession 0001193125-23-103731
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Spyre Therapeutics, Inc.
- Ticker
- SYRE
- CIK
- 1636282
- Form type
- DEF 14A
- Filing date
- Apr 17, 2023
- Report date
- Jun 6, 2023
- Document
- d449732ddef14a.htm
- Size
- 961 KB